FDA inspection
Qilu Pharmaceutical Co., Ltd. (Dongjia Site): FDA inspection ending Jun 16, 2023
FDA inspection 1210768 · Official Action Indicated (OAI) · Jinan
Key facts
| Inspection ID | 1210768 |
|---|---|
| Firm | Qilu Pharmaceutical Co., Ltd. (Dongjia Site) |
| FEI number | 3021324493 |
| Address | No. 849 Dongjiazhen Licheng |
| City | Jinan |
| Fiscal year | 2023 |
| Inspection end date | Jun 16, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data